Selective Serotonin Reuptake Inhibitors for Premenstrual Dysphoric Disorder: The Emerging Gold Standard?

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.13, 2002-01, pp. : 1869-1885

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Serotonin Reuptake Inhibitors in the Treatment of Social Phobia: The Emerging Gold Standard

By Ameringen M.V.

CNS Drugs, Vol. 11, Iss. 4, 1999-04 ,pp. : 307-315

Adis International

Access to resources Recommend Favorite

Are there Differential Symptom Profiles that Improve in Response to Different Pharmacological Treatments of Premenstrual Syndrome/Premenstrual Dysphoric Disorder?

By Halbreich Uriel

CNS Drugs, Vol. 20, Iss. 7, 2006-01 ,pp. : 523-547

Adis International

Access to resources Recommend Favorite

Discontinuation Syndromes with Selective Serotonin Reuptake Inhibitors: Are There Clinically Relevant Differences?

By Olver J.S. Burrows G.D. Norman T.R.

CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. : 171-177

Adis International

Access to resources Recommend Favorite

Drug-eluting stents for angioplasty: the new gold standard?

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

By Macdougall Mary Steiner Meir

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite